Accurun 121 Hav Igm Positive Control
FDA 510(k) K971657 · Boston Biomedica, Inc.
510(k) numberK971657
Submission
- Device name
- Accurun 121 Hav Igm Positive Control
- Applicant
- Boston Biomedica, Inc.
West Bridgewater, MA, US - Received
- May 6, 1997
- Decision date
- August 12, 1997
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) statement available from FDA
Device classification
- Product code
- JJY – Multi-Analyte Controls, All Kinds (Assayed)
- Device class
- Class I (low risk)
- Regulation
- 21 CFR 862.1660
- Specialty
- Clinical Chemistry
Other 510(k)s with product code JJY
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K162530 | Multichem IA PlusJJY · Abbreviated | Techno-Path Manufacturing | 03/31/2017SE |
| K163629 | Audit MicroControls Linearity FD Tumor Markers IIJJY · Traditional | Aalto Scientific, Ltd. | 03/10/2017SE |
| K163015 | Liquichek Tumor Marker Control-Level 1; Liquichek Tumor Marker Control-Level 2…JJY · Traditional | Bio-Rad Laboratories | 01/10/2017SE |
| K153712 | VK-3 Verification Kit, VK-4 Verification Kit, VK-R5 Verification Kit, VK-R7 Verification…JJY · Traditional | Radiometer America, Inc. | 01/28/2016SE |
| K150300 | Liquichek Cardiac Markers Plus Control LTJJY · Traditional | Bio-Rad Laboratories | 12/11/2015SE |
| K142964 | VALIDATE Anemia Calibration Verification/ Linearity Test KitJJY · Traditional | Maine Standards Company, LLC | 04/30/2015SE |
| K143379 | Liquichek Maternal Serum II ControlJJY · Traditional | Bio-Rad Laboratories | 03/13/2015SE |
| K143573 | Audit MicroControls Linearity FD Tumor Markers IIJJY · Traditional | Aalto Scientific, Ltd. | 01/16/2015SE |
| K140971 | Liquid Assayed Chemistry Control Premium Plus Level 1,2 and Level 3.JJY · Traditional | Randox Laboratories Limited | 12/08/2014SE |
| K142978 | Audit MicroControls Linearity LQ Special DiabetesJJY · Traditional | Aalto Scientific, Ltd. | 11/20/2014SE |
More from Aalto Scientific, Ltd.
| 510(k) | Device | Decision |
|---|---|---|
| K032713 | Boston Biomedica, Inc. Borrelia Burgdorferi Igm and IggLSR · Traditional | 11/24/2003SE |
| K980351 | Bbi-Biotech Research Laboratories B. Burgdorferi Igm Western Blot KitLSR · Traditional | 03/05/1999SE |
| K974811 | Accurun(Tm) 150 HSV Igg Positive ControlJJX · Traditional | 02/10/1998SE |
| K974810 | Accurun(Tm) 132 Borrelia Burdorferi Igm Positive ControlLSR · Traditional | 02/05/1998SE |
| K974809 | Accurun(Tm) 130 Borrelia Burgdorferi Igg Positive ControlLSR · Traditional | 02/05/1998SE |
| K974261 | Accurun 135 Toxoplasma Igg Positive ControlLJK · Traditional | 12/11/1997SE |
| K972986 | Accurun 140 Rubella Igg Positive ControlMJX · Traditional | 10/08/1997SE |
| K972884 | Accurun 146 CMV Igm Positive ControlLKQ · Traditional | 08/22/1997SE |
| K972048 | Accurun 117 Hbeag Positive ControlJJY · Traditional | 08/12/1997SE |
| K972307 | Accurun 119 Anti-Hepatitis B E Antigen (Anti-Hbe) Positive ControlJJY · Traditional | 08/07/1997SE |
Questions and answers
When was Accurun 121 Hav Igm Positive Control cleared by the FDA?
Accurun 121 Hav Igm Positive Control (K971657) received a 510(k) decision of Substantially Equivalent on August 12, 1997, 98 days after the submission was received.
What is the product code of K971657?
The FDA product code is JJY – Multi-Analyte Controls, All Kinds (Assayed), a Class I (low risk) device regulated under 21 CFR 862.1660.